Publications

Our research addresses key public health priorities such as genomics research and substance use epidemiology and policy.

 

We led these publications during 2021:

Bourdon JL, Dorsey A, Zalik M, Pietka A, Salyer P, Bray MJ, Bierut LJ, Ramsey AT. In-vivo design feedback and perceived utility of a genetically-informed smoking risk tool among current smokers in the community. BMC Med Genomics. 2021 May 26;14(1):139.

Bray MJ, Chen LS, Fox L, Ma Y, Grucza RA, Hartz SM, Culverhouse RC, Saccone NL, Hancock DB, Johnson EO, McKay JD, Baker TB, Bierut LJ. Studying the utility of using genetics to predict smoking-related outcomes in a population-based study and a selected cohort. Nicotine Tob Res. 2021 May 15:ntab100. doi: 10.1093/ntr/ntab100.

Cavazos-Rehg P, Byansi W, Doroshenko C, Neilands TB, Anako N, Sensoy Bahar O, Kasson E, Nabunya P, Mellins CA, Ssewamala FM. Evaluating potential mediators for the impact of a family-based economic intervention (Suubi+Adherence) on the mental health of adolescents living with HIV in Uganda. Soc Sci Med. 2021 Jul;280:113946.

Cavazos-Rehg P, Byansi W, Xu C, Nabunya P, Sensoy Bahar O, Borodovsky J, Kasson E, Anako N, Mellins C, Damulira C, Neilands T, Ssewamala FM. The impact of a family-based economic intervention on the mental health of HIV-infected adolescents in Uganda: Results from Suubi + Adherence. J Adolesc Health. 2021 Apr;68(4):742-749.

Cavazos-Rehg P, Li X, Kasson E, Kaiser N, Borodovsky J, Grucza RA. Investigating the role of familial and peer-related factors on electronic nicotine delivery systems (ENDS) use among US adolescents. J Adolesc. 2021 Feb; 87:98-105.

Cavazos-Rehg P, Xu C, Krauss MJ, Min C, Winograd R, Grucza R, Bierut LJ. Understanding barriers to treatment among individuals not engaged in treatment who misuse opioids: A structural equation modeling approach. Subst Abus. 2021 Feb 22:1-20. doi: 10.1080/08897077.2021.1876199.

Ho JTK, Tyndale RF, Baker TB, Amos CI, Chiu A, Smock N, Chen J, Bierut LJ, Chen LS. Racial disparities in intensity of smoke exposure and nicotine intake among low-dependence smokers. Drug Alcohol Depend. 2021 Feb 18; 221:108641.

Li X, Borodovsky JT, Kasson EM, Fentem A, Cavazos-Rehg PA. An analysis of within-subject and population level risk related to substance use and mental health outcomes among adolescents in the PATH study. Drug Alcohol Depend. 2021 Jan 1; 218:108385.

Mintz CM, Hartz SM, Fisher SL, Ramsey AT, Geng EH, Grucza RA, Bierut LJ. A cascade of care for alcohol use disorder: Using 2015-2019 National Survey on Drug Use and Health data to identify gaps in past 12-month care. Alcohol Clin Exp Res. 2021 Jun;45(6):1276-1286.

Mintz CM, Presnall NJ, Xu KY, Hartz SM, Sahrmann JM, Bierut LJ, Grucza RA. An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders. Drug Alcohol Depend. 2021 Jun 25;226:108886.

Xu KY, Presnall N, Mintz CM, Borodovsky JT, Bhat N, Bierut LJ, Grucza RA. Association of opioid use disorder treatment with alcohol-related acute events. JAMA Network Open. 2021 Feb 24. 4(2):e210061.

Xu KY, Borodovsky JT, Presnall N, Mintz CM, Hartz SM, Bierut LJ, Grucza RA. Association between benzodiazepine or z-drug prescriptions and drug-related poisonings among patients receiving buprenorphine maintenance: a case-crossover analysis. American Journal of Psychiatry.  2021 Mar 3; appiajp202020081174.

 

We co-authored these publications during 2021:

Bousman CA, Bengesser SA, Aitchison KJ, Amare AT, Aschauer H, Baune BT, Asl BB, Bishop JR, Burmeister M, Chaumette B, Chen LS, Cordner ZA, Deckert J, Degenhardt F, DeLisi LE, Folkersen L, Kennedy JL, Klein TE, McClay JL, McMahon FJ, Musil R, Saccone NL, Sangkuhl K, Stowe RM, Tan EC, Tiwari AK, Zai CC, Zai G, Zhang J, Gaedigk A, Müller DJ. Review and consensus on pharmacogenomics testing in psychiatry. Pharmacopsychiatry. 2021 Jan; 54(1):5-17.

Johnson EC, Kapoor M, Hatoum AS, Zhou H, Polimanti R, Wendt FR, Walters RK, Lai D, Kember RL, Hartz S, Meyers JL, Peterson RE, Ripke S, Bigdeli TB, Fanous AH, Pato CN, Pato MT, Goate AM, Kranzler HR, O’Donovan MC, Walters JTR, Gelernter J, Edenberg HJ, Agrawal A. Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder. Psychol Med. 2021 Jul 7:1-9. doi: 10.1017/S003329172100266X.

Jones EE, Ramsey AT, Wesselmann ED, Rosenthal HJ, Hesson-McInnis MS. Being ostracized versus out of the loop: Redundant or unique predictors of variance in workplace outcomes? J Appl Soc Psychol. 2021 Jan;51(1):17-31.

Markunas CA, Semick SA, Quach BC, Tao R, Deep-Soboslay A, Carnes MU, Bierut LJ, Hyde TM, Kleinman JE, Johnson EO, Jaffe AE, Hancock DB. Genome-wide DNA methylation differences in nucleus accumbens of smokers vs. nonsmokers. Neuropsychopharmacology. 2021 Feb; 46(3):554-560.

Mozersky J, Hartz S, Linnenbringer E, Levin L, Streitz M, Stock K, Moulder K, Morris JC. Communicating 5-year risk of Alzheimer’s disease dementia: Development and evaluation of materials that incorporate multiple genetic and biomarker research results. J Alzheimers Dis. 2021;79(2):559-572.

Palmer RHC, Johnson EC, Won H, Polimanti R, Kapoor M, Chitre A, Bogue MA, Benca-Bachman CE, Parker CC, Verma A, Reynolds T, Ernst J, Bray M, Kwon SB, Lai D, Quach BC, Gaddis NC, Saba L, Chen H, Hawrylycz M, Zhang S, Zhou Y, Mahaffey S, Fischer C, Sanchez-Roige S, Bandrowski A, Lu Q, Shen L, Philip V, Gelernter J, Bierut LJ, Hancock DB, Edenberg HJ, Johnson EO, Nestler EJ, Barr PB, Prins P, Smith DJ, Akbarian S, Thorgeirsson T, Walton D, Baker E, Jacobson D, Palmer AA, Miles M, Chesler EJ, Emerson J, Agrawal A, Martone M, Williams RW. Integration of evidence across human and model organism studies: A meeting report. Genes Brain Behav. 2021 Apr 23:e12738.

Rahman T, Patrick C, Ma C, Nicol GE, Reynolds CF 3rd, Mulsant BH, Hartz SM, Yingling M, Lenze EJ. Prolactin and estrogen levels in postmenopausal women receiving aripiprazole augmentation treatment for depression. J Clin Psychopharmacol. 2021 Jan/Feb 01;41(1):31-35.

Salloum RG, D’Angelo H, Theis RP, Rolland B, Hohl S, Pauk D, LeLaurin JH, Asvat Y, Chen LS, Day AT, Goldstein AO, Hitsman B, Hudson D, King AC, Lam CY, Lenhoff K, Levinson AH, Prochaska J, Smieliauskas F, Taylor K, Thomas J, Tindle H, Tong E, White JS, Vogel WB, Warren GW, Fiore M. Mixed-methods economic evaluation of the implementation of tobacco treatment programs in National Cancer Institute-designated cancer centers. Implement Sci Commun. 2021 Apr 9;2(1):41.

Saunders EC, Moore SK, Walsh O, Metcalf SA, Budney AJ, Cavazos-Rehg P, Scherer E, Marsch LA. “It’s way more than just writing a prescription”: A qualitative study of preferences for integrated versus non-integrated models among individuals with opioid use disorder. Addict Sci Clin Pract. 2021 Jan 27; 16(1):8.

Publications archive: